Top Page
British American Tobacco
(LSE:BATS)
British American Tobacco (BATS) vs. iShares MSCI United Kingdom ETF (EWC)
British American Tobacco Business Overview & Revenue Model
British American Tobacco Earnings Call Summary
British American Tobacco Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 25.87B | 27.28B | 27.66B | 25.68B | 25.78B |
| Gross Profit | 21.43B | 22.39B | 22.85B | 21.09B | 21.33B |
| EBITDA | 7.74B | 13.28B | 12.38B | 11.19B | 10.71B |
| Net Income | 3.07B | -14.37B | 6.67B | 6.80B | 6.40B |
Balance Sheet | |||||
| Total Assets | 118.90B | 118.72B | 153.55B | 137.37B | 137.69B |
| Cash, Cash Equivalents and Short-Term Investments | 5.81B | 5.26B | 4.03B | 3.27B | 3.38B |
| Total Debt | 36.95B | 39.73B | 43.14B | 39.66B | 43.97B |
| Total Liabilities | 68.90B | 65.78B | 77.84B | 69.96B | 74.73B |
| Stockholders Equity | 49.64B | 52.57B | 75.37B | 67.10B | 62.67B |
Cash Flow | |||||
| Free Cash Flow | 9.52B | 10.25B | 9.87B | 9.19B | 9.28B |
| Operating Cash Flow | 10.13B | 10.71B | 10.39B | 9.72B | 9.79B |
| Investing Cash Flow | 1.38B | -296.00M | -705.00M | -1.14B | -783.00M |
| Financing Cash Flow | -10.63B | -9.31B | -8.88B | -8.75B | -7.90B |
British American Tobacco Technical Analysis
British American Tobacco Risk Analysis
British American Tobacco Peers Comparison
British American Tobacco Corporate Events
British American Tobacco has announced the repurchase of 108,775 of its ordinary shares as part of its ongoing buyback program. The company intends to cancel these shares, which will result in a reduction of its total shares in issue to 2,195,796,448, excluding treasury shares. This move is likely to impact shareholder interests and aligns with the company’s strategy to manage its capital structure effectively.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 92,400 ordinary shares as part of its ongoing buyback program. This transaction, executed through Merrill Lynch International, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in issue and potentially impacting shareholder voting rights and interest notifications.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 86,471 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted through Merrill Lynch International, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The repurchased shares will be canceled, reducing the total number of shares in circulation, which may influence shareholder notifications under FCA rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £32.50 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco PLC has executed a share buyback, purchasing 83,710 of its ordinary shares at an average price of 3,607.7966 pence per share. This move, part of a previously announced buyback program, aims to cancel the acquired shares, potentially impacting shareholder interests and the company’s share capital structure.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 85,202 of its ordinary shares as part of its ongoing buyback program. This transaction, executed through Merrill Lynch International, is part of the company’s strategy to manage its capital structure and provide value to shareholders. The repurchased shares will be canceled, reducing the total number of shares in circulation and potentially impacting shareholder voting rights and interests.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a transaction involving the sale of shares by James Barrett, Director of Business Development. The transaction, which involved the sale of 4,915 ordinary shares at a price of £36.73274 each, took place on the London Stock Exchange, totaling £180,541.417. This notification highlights the company’s ongoing transparency in disclosing managerial transactions, which could impact stakeholder perceptions and market dynamics.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 91,350 of its ordinary shares as part of its ongoing buyback program. The shares were purchased at a volume-weighted average price of 3,648.8058 pence per share and will be canceled, reducing the total number of shares in issue. This move is part of the company’s strategy to enhance shareholder value and manage its capital structure effectively.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has announced the repurchase of 86,453 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted through Merrill Lynch International, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The repurchased shares will be canceled, reducing the total number of shares in circulation and potentially impacting shareholder voting rights and interest notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase and cancellation of 89,586 ordinary shares as part of its ongoing buyback program. This move, authorized by shareholders, is expected to impact the company’s share capital structure, potentially influencing shareholder interests and market perceptions.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the details of its August 2025 dividend payment, which is part of a previously declared interim dividend for the year ended December 2024. The dividend will be paid to shareholders on the UK main register and the South Africa branch register, with specific exchange rates and tax implications for South African shareholders. This announcement reinforces the company’s commitment to returning value to its shareholders, while also highlighting the financial implications for those on the South Africa branch register due to currency exchange and tax considerations.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has repurchased 87,819 of its ordinary shares as part of a buyback program, with the intention to cancel these shares. This move will reduce the number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback program, purchasing 87,960 ordinary shares at an average price of 3,565.8640 pence per share. This move, authorized by shareholders, aims to cancel the acquired shares, thereby reducing the total number of shares in circulation and potentially enhancing shareholder value. The transaction reflects the company’s strategic financial management and could impact shareholder interests by altering voting rights and shareholding structures.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco PLC announced the purchase of 115,990 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted through Merrill Lynch International, is part of the company’s strategy to manage its capital structure. The purchased shares will be canceled, reducing the number of shares in circulation and potentially increasing shareholder value by boosting earnings per share. This move reflects the company’s commitment to returning value to shareholders and maintaining a strong market position.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has repurchased 115,438 of its ordinary shares as part of a buyback program, with plans to cancel these shares. This transaction, executed through Merrill Lynch International, is part of the company’s strategy to manage its share capital and could impact shareholder interests and voting rights.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a change in the voting rights of its shares, following an acquisition by The Capital Group Companies, Inc. This acquisition has increased the voting rights held by The Capital Group to 18.068752%, up from a previous 17.017042%. This change reflects a significant shift in shareholder influence, potentially impacting company decisions and stakeholder interests.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the repurchase of 115,251 of its ordinary shares as part of its ongoing buyback program. This move, authorized by shareholders, aims to enhance shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and strengthening the company’s market position.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 119,037 of its ordinary shares at an average price of 3,451.0771 pence per share. This move is part of a broader buyback program and aims to cancel the purchased shares, potentially impacting the company’s share value and stakeholder interests.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £30.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the purchase of ordinary shares by several of its top executives, including the Chief Executive, Chief Financial Officer, and other directors, under the Partnership Share Scheme. This move, conducted on the London Stock Exchange, demonstrates the company’s commitment to aligning the interests of its management with those of its shareholders, potentially impacting its market positioning and stakeholder relations positively.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £30.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 123,502 of its ordinary shares as part of its ongoing buyback program. The shares, purchased from Merrill Lynch International, will be canceled, reducing the total number of shares in issue and potentially increasing shareholder value. This move is part of the company’s strategy to optimize its capital structure and return value to shareholders.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £30.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 123,294 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This transaction, conducted through Merrill Lynch International, is part of the company’s strategy to manage its capital structure and enhance shareholder value, potentially impacting its share price and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a transaction involving the repurchase of 119,368 of its ordinary shares, as part of a buyback program authorized by shareholders. The shares were purchased from Merrill Lynch International and will be canceled, reducing the total number of shares in issue to 2,197,514,957. This move is part of the company’s strategy to manage its capital structure and may impact shareholder interests as it adjusts the number of shares carrying voting rights.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has reported that its revenue performance for the first half of 2025 is slightly ahead of previous guidance, with expectations for full-year revenue growth of 1-2%. The company anticipates a return to revenue and profit growth in the U.S., driven by strong performance in its combustibles and modern oral segments, despite challenges in the vapour category due to illicit products. BAT is focusing on deploying new innovations in key markets to drive growth in the second half of the year. The company is also working towards financial flexibility by partially monetizing its ITC stake and committing to reducing leverage by 2026, while maintaining a progressive dividend and share buy-back program.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced its issued share capital as of May 30, 2025, which consists of over 2.19 billion ordinary shares, with a significant portion held in treasury. This update is crucial for shareholders to calculate their voting rights and any changes in their interest, aligning with the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback transaction, purchasing 125,822 of its ordinary shares at a volume-weighted average price of 3,330.6572 pence per share. The company intends to cancel these shares, reducing the total number of shares in issue to 2,197,634,325, which may impact shareholder interests under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 126,884 ordinary shares at an average price of 3,309.5614 pence per share. This move, authorized by shareholders, is part of the company’s ongoing buyback program and will result in the cancellation of these shares, reducing the total number of shares in circulation. This action is likely to impact shareholder value by potentially increasing earnings per share and reflects the company’s commitment to returning value to shareholders.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 123,456 of its ordinary shares at an average price of 3,333.2523 pence per share. This move, authorized by shareholders, is part of a broader buyback program and will result in the cancellation of the purchased shares, reducing the number of shares in circulation and potentially enhancing shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has completed a block trade of 313 million ordinary shares in ITC Limited, raising approximately £1.05 billion. The proceeds will enhance BAT’s financial flexibility, support its transformation investments, and extend its share buyback program by £200 million, totaling £1.1 billion in repurchases for 2025. This move is expected to bolster shareholder returns and strengthen BAT’s market positioning.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback program, purchasing 121,839 of its ordinary shares at a volume-weighted average price of 3,327.8563 pence per share. This move, authorized by shareholders, is part of a broader strategy to optimize capital structure and enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder voting rights and require notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the sale of approximately 2.3% of its shares in ITC Limited through an accelerated bookbuild process to institutional investors. This transaction aims to provide BAT with increased financial flexibility, supporting its commitment to transformation, deleveraging, and sustainable shareholder returns. The proceeds will help BAT reach its target leverage corridor by 2026 and increase its share buyback program. Despite the sale, BAT will maintain a significant 23.1% stake in ITC and continues to view ITC as a strategic partner in India, a market with long-term growth potential.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco (BAT) is considering the sale of a portion of its shareholding in ITC Limited through an on-market trade. While the company evaluates this potential disposal, there is no certainty regarding the transaction’s execution or terms. This move could impact BAT’s financial strategy and market positioning, as it continues to focus on its smokeless product portfolio and sustainability goals.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 127,368 of its own ordinary shares as part of its ongoing buyback program. This transaction, conducted with Merrill Lynch International, is part of a strategy to reduce the number of shares in circulation, potentially increasing the value of remaining shares and enhancing shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the repurchase of 126,670 of its ordinary shares as part of its ongoing buyback program. This move, authorized by shareholders, aims to reduce the number of shares in circulation, potentially enhancing shareholder value and adjusting the company’s capital structure.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has disclosed a transaction involving James Barrett, Director of Business Development, who transferred 4,915 ordinary shares between his own accounts for nil consideration. This transaction, conducted outside a trading venue, reflects internal adjustments and does not directly impact the company’s market operations or stakeholder interests.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 127,404 of its ordinary shares as part of a buyback program, with plans to cancel these shares. This move is intended to optimize the company’s capital structure and could potentially enhance shareholder value by reducing the number of shares in circulation, thereby increasing the value of remaining shares.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback program, purchasing 130,580 of its ordinary shares at an average price of 3,213.57 pence per share. This move is part of a broader strategy to enhance shareholder value, as the company plans to cancel these shares, thereby reducing the total number of shares in circulation and potentially increasing the value of remaining shares.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a change in its voting rights structure, with Spring Mountain Investments Ltd now holding 5.251446% of the voting rights. This adjustment, down from a previous position of 6.971493%, reflects a significant shift in shareholder influence and could impact the company’s strategic decisions and stakeholder dynamics.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 133,097 of its ordinary shares at a volume-weighted average price of 3,147.6540 pence per share. This move is part of the company’s ongoing buyback program and aims to reduce the number of shares in circulation, potentially enhancing shareholder value. Following the cancellation of these shares, the company will have 2,198,637,109 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 137,397 of its ordinary shares as part of a buyback program, with the highest price paid per share being 3,071 pence. The company intends to cancel these shares, reducing the number of shares in circulation, which may impact shareholder notifications under FCA rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 138,569 ordinary shares at an average price of 3,030.7749 pence per share. This move, part of a broader buyback program, aims to cancel the acquired shares, thereby reducing the total number of shares in circulation and potentially increasing shareholder value. The transaction reflects the company’s strategic focus on enhancing shareholder returns and optimizing its capital structure.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback, purchasing 135,953 of its ordinary shares as part of a program authorized by shareholders. This move, involving the cancellation of the acquired shares, aims to optimize the company’s capital structure and potentially enhance shareholder value. Following this transaction, the company will have 2,199,044,110 ordinary shares in issue, excluding treasury shares, which may influence shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the acquisition of shares by its Chief Executive, Tadeu Marroco, and Luciana Franco Do Amaral, a person closely associated with him. The transaction, conducted on the London Stock Exchange, involved the reinvestment of dividend income to acquire ordinary shares, highlighting a strategic move to strengthen their stake in the company.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 135,845 ordinary shares at prices ranging from 3,050.00p to 3,150.00p, with an average of 3,090.1409p per share. This move, part of a previously announced buyback program, aims to cancel the purchased shares, thereby reducing the number of shares in circulation and potentially increasing shareholder value. Following this transaction, the company will have 2,199,172,149 shares in issue and 133,013,619 shares held in treasury, impacting shareholder notifications under the FCA’s rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a change in its voting rights structure following an acquisition or disposal of voting rights by Spring Mountain Investments Ltd. The transaction has resulted in Spring Mountain Investments Ltd holding 6.971493% of the voting rights, down from a previous 7.285760%. This adjustment in voting rights could influence the company’s governance and decision-making processes, impacting stakeholders and potentially affecting the company’s strategic direction.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a transaction involving Jerome Abelman, the Director, Legal and General Counsel, who acquired shares following the exercise of options under the 2020 British American Tobacco 5 Year Sharesave Scheme. The transaction involved the acquisition of 1,249 ordinary shares at a total price of £29,988.49, conducted outside a trading venue on May 8, 2025. This transaction reflects the company’s ongoing commitment to employee share ownership, potentially impacting stakeholder perceptions and aligning managerial interests with shareholder value.
British American Tobacco announced the repurchase of 132,387 of its ordinary shares as part of its ongoing buyback program. This move, executed through Merrill Lynch International, reflects the company’s strategy to manage its capital structure and enhance shareholder value. The repurchased shares will be canceled, reducing the total number of shares in circulation and potentially impacting shareholder voting rights.
British American Tobacco has announced a change in major holdings, with Spring Mountain Investments Ltd now holding 7.285760% of the voting rights. This adjustment in holdings could influence the company’s strategic decisions and impact its stakeholders, reflecting a shift in the control dynamics within the company.
British American Tobacco announced that several of its executives, including the CEO and COO, have acquired ordinary shares through the reinvestment of dividend income as part of the company’s Share Incentive Plan. This move reflects the company’s ongoing commitment to aligning the interests of its management with those of its shareholders, potentially strengthening stakeholder confidence and enhancing market positioning.
British American Tobacco announced that several of its senior executives, including regional directors and the Chief Marketing Officer, have acquired ordinary shares in the company through the reinvestment of dividend income. This transaction, conducted on May 7, 2025, on the London Stock Exchange, reflects the company’s ongoing commitment to aligning the interests of its leadership with those of its shareholders, potentially strengthening stakeholder confidence.
British American Tobacco has announced transactions involving its Chief Executive, Tadeu Marroco, and Chief Financial Officer, Soraya Benchikh, who acquired shares under the company’s Deferred Share Bonus Scheme and Long-Term Incentive Plan. These transactions, which took place outside a trading venue, reflect the company’s ongoing commitment to aligning management interests with shareholder value, potentially impacting the company’s market positioning and stakeholder confidence.
British American Tobacco has announced a transaction involving the credit of additional Deferred Stock Units (DSUs) to Non-Executive Director Holly Keller Koeppel. This transaction is linked to the value of dividends declared on the company’s American Depositary Shares (ADSs) and is part of the Reynolds American Inc. Amended and Restated Deferred Compensation Plan. The transaction, which took place outside a trading venue, reflects the company’s ongoing commitment to aligning executive compensation with shareholder interests.
British American Tobacco has repurchased 127,462 of its ordinary shares as part of a buyback program authorized by shareholders. This move, involving shares purchased at an average price of 3,287.2119 pence, is intended to reduce the number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests.
British American Tobacco has announced a transaction involving Paul McCrory, Director of Corporate & Regulatory Affairs, who acquired shares following the exercise of options under the 2022 Sharesave Scheme. This transaction, involving 660 ordinary shares at a price of £17,998.20, reflects ongoing managerial engagement with the company’s equity, potentially impacting stakeholder perceptions of executive confidence in the company’s future performance.
British American Tobacco has announced a transaction involving the transfer of 3,332 ordinary shares from James Murphy, Director of Research and Science, to Kirsti Nordgard Murphy, a person closely associated with him. The transaction was conducted outside a trading venue and was reported as an initial notification. This transfer of shares highlights internal movements within the company’s managerial responsibilities, potentially impacting stakeholders’ perceptions of corporate governance and internal control.
British American Tobacco has announced that several of its executive directors and senior managers, including the Chief Executive and Chief Financial Officer, have purchased ordinary shares in the company through the Partnership Share Scheme. This move, conducted on the London Stock Exchange, reflects a commitment to align the interests of the company’s leadership with those of its shareholders, potentially impacting the company’s market perception and stakeholder confidence.
British American Tobacco p.l.c. has executed a share buyback transaction, purchasing 126,860 of its ordinary shares at an average price of 3,308.6193 pence per share. This move is part of a broader buyback program and will result in the cancellation of these shares, reducing the total number of shares in circulation and potentially impacting shareholder value and voting rights.
British American Tobacco p.l.c. announced the repurchase of 127,236 of its ordinary shares as part of its ongoing buyback program. This transaction, authorized by shareholders, aims to enhance shareholder value by reducing the number of shares in circulation, thereby potentially increasing earnings per share. The cancellation of these shares will adjust the total number of shares in issue, which could impact shareholder notifications under regulatory rules.
British American Tobacco has announced a change in its voting rights structure, following an acquisition or disposal of voting rights by Spring Mountain Investments Ltd. The notification indicates that the voting rights held by the company have decreased from 8.500645% to 7.931114%, impacting the company’s shareholder composition and potentially influencing future corporate decisions.
British American Tobacco has amended a previous announcement regarding a share transaction involving its Chief Corporate Officer, Kingsley Wheaton. The amendment corrects the nature of the transaction, indicating that shares were transferred from Kingsley Wheaton to Yulia Wheaton, a person closely associated with him. This update clarifies the transaction details but does not alter any other information, ensuring transparency in the company’s managerial dealings.
British American Tobacco p.l.c. has executed a share buyback transaction, purchasing 123,609 of its ordinary shares at a volume-weighted average price of 3,233.7267 pence per share. The company plans to cancel these shares, reducing the number of shares in circulation and potentially increasing the value of remaining shares. This move is part of a broader buyback program aimed at optimizing capital structure and enhancing shareholder value.
British American Tobacco has announced a transaction involving the transfer of 23,596 ordinary shares by Kingsley Wheaton, the Chief Corporate Officer, to Yulia Wheaton, a person closely associated with him. This transaction, which took place outside a trading venue, was conducted at no cost. The announcement highlights internal share movements within the company, potentially impacting the company’s internal shareholding structure and stakeholder interests.
British American Tobacco announced transactions involving its Chief Executive, Tadeu Marroco, and Chief Marketing Officer, Luciano Comin, who acquired shares following the exercise of options under the company’s Sharesave Schemes. These transactions, conducted outside a trading venue, reflect the executives’ engagement with the company’s equity plans, potentially signaling confidence in the company’s future performance.
British American Tobacco p.l.c. announced the repurchase of 125,000 of its ordinary shares as part of its ongoing buyback program. The shares were purchased at a volume-weighted average price of 3,240.1141 pence and will be canceled, reducing the total number of shares in circulation. This move is part of the company’s strategy to enhance shareholder value, potentially impacting its market positioning by consolidating ownership and improving financial metrics.
British American Tobacco has announced a transaction involving the transfer of 15,617 ordinary shares by Zafar Khan, Director of Operations, to Mahgul Aslam Khan, a person closely associated with him. The transaction, conducted outside a trading venue on April 30, 2025, was reported as an initial notification and involved no monetary exchange. This internal share transfer highlights the company’s ongoing internal management and ownership structuring, potentially impacting stakeholder perceptions of governance and transparency.
British American Tobacco has announced its issued share capital as of April 30, 2025, consisting of over 2.2 billion ordinary shares, with a portion held in treasury. This update is crucial for shareholders to assess their voting rights and any changes in their interest in compliance with regulatory guidelines.
British American Tobacco p.l.c. has executed a share buyback transaction, purchasing 126,642 of its ordinary shares at prices ranging from 3,189 to 3,270 pence per share. This move, part of a broader buyback program, aims to cancel the acquired shares, thereby reducing the total number of shares in circulation and potentially increasing shareholder value. Following this transaction, the company will have 2,200,042,944 ordinary shares in issue, excluding treasury shares, and 133,013,619 shares held in treasury. This strategic financial maneuver is likely to impact the company’s market positioning by enhancing shareholder returns and optimizing capital structure.
British American Tobacco PLC has announced a new phase in its share buyback programme, set to commence on 1 May 2025 and conclude on 30 June 2025. The company has entered into a non-discretionary agreement with Merrill Lynch International to purchase up to 220,451,469 ordinary shares, aiming to reduce its share capital. This move is expected to enhance shareholder value by decreasing the number of shares in circulation, potentially increasing earnings per share and maintaining compliance with regulatory standards.
British American Tobacco has executed a share buyback program, purchasing 130,042 of its ordinary shares at an average price of 3,152.8257 pence per share. This move, authorized by shareholders, is part of the company’s strategy to manage its capital structure and enhance shareholder value. Following the cancellation of these shares, the company will have 2,200,169,586 ordinary shares in issue, which may impact shareholder notifications under regulatory guidelines.
British American Tobacco has announced a notification of major holdings, indicating a change in the voting rights attached to its shares. This notification was prompted by an acquisition or disposal of voting rights by Spring Mountain Investments Ltd, a company registered in the Cayman Islands. The resulting situation shows a slight decrease in the percentage of voting rights held, which may impact the company’s governance structure and influence within the industry.
British American Tobacco has executed a share buyback, purchasing 130,037 ordinary shares from UBS AG as part of its ongoing buyback program. This move, approved by shareholders, aims to reduce the number of shares in circulation, potentially increasing the value of remaining shares and signaling confidence in the company’s financial health.
British American Tobacco PLC announced the repurchase of 128,580 of its ordinary shares as part of its ongoing buyback program. The shares were purchased at a volume-weighted average price of 3,188.6584 pence and will be canceled, reducing the total number of shares in issue and potentially impacting shareholder interests under FCA regulations.
British American Tobacco has executed a share buyback program, purchasing 129,632 of its ordinary shares at prices ranging from 3,129 to 3,201 pence per share. This move, approved by shareholders, aims to cancel the purchased shares, reducing the total number of shares in issue and potentially enhancing shareholder value. Following this transaction, the company will have 2,200,558,245 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under FCA rules.
British American Tobacco has announced a change in the voting rights associated with its shares, following an acquisition or disposal by Spring Mountain Investments Ltd. The notification indicates that the threshold for voting rights was crossed on April 17, 2025, with a resulting position of 8.899793% of voting rights attached to shares. This change may impact the company’s governance and influence within the industry, as stakeholders adjust to the new distribution of voting power.
British American Tobacco p.l.c. announced the repurchase of 128,536 of its ordinary shares as part of its ongoing buyback program. The shares were purchased at prices ranging from 3,173.00 to 3,205.00 pence per share, with the company planning to cancel these shares, thereby reducing the total number of shares in circulation. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
British American Tobacco announced the granting of ordinary shares to its Executive Directors under the Performance Share Plan. This move, involving significant share awards to key executives, underscores the company’s commitment to aligning leadership incentives with performance goals, potentially impacting its operational focus and stakeholder interests.
British American Tobacco has announced a notification of major holdings, indicating a change in voting rights due to an acquisition or disposal. The notification involves Spring Mountain Investments Ltd, which now holds 9.219762% of voting rights, down from a previous 9.996713%. This adjustment in holdings could impact the company’s governance and influence stakeholder decisions.
British American Tobacco p.l.c. announced the purchase of 129,740 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted through UBS AG, is in line with the authority granted by shareholders and aims to reduce the number of shares in circulation, potentially enhancing shareholder value. Following this buyback, the company will have 2,200,816,413 ordinary shares in issue, excluding treasury shares, which carry voting rights. This move is part of the company’s strategy to manage its capital structure and could have implications for shareholder notifications under regulatory guidelines.
British American Tobacco p.l.c. announced the repurchase of 128,370 of its ordinary shares as part of its ongoing buyback program. This transaction, authorized by shareholders, is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in issue, which may impact shareholder voting rights and interest notifications under regulatory guidelines.
British American Tobacco p.l.c. announced the successful passing of all 21 resolutions at its 2024 Annual General Meeting, held on April 16, 2025. Key resolutions included the approval of the 2025 Directors’ Remuneration Policy and the reappointment of KPMG LLP as auditors. The results reflect strong shareholder support, with most resolutions receiving over 90% approval. This outcome underscores the company’s stable governance and strategic direction, reinforcing its position in the industry and providing confidence to its stakeholders.
British American Tobacco’s 2025 AGM highlighted the company’s strategic progress and commitment to becoming a predominantly smokeless business by 2035. Despite a 5.2% decline in reported revenue for 2024, the company saw a 1.3% increase on an organic basis, driven by growth in its New Categories business. BAT’s refined strategy focuses on quality growth, sustainability, and dynamic business operations, with a strong emphasis on tobacco harm reduction. The company aims to enhance consumer acceptance of smokeless products and address regulatory challenges. Looking ahead, BAT expects to return to profit growth in the U.S. and plans to continue its transformation with significant product innovations and a focus on sustainability.
British American Tobacco has announced the purchase and cancellation of 128,457 ordinary shares as part of its ongoing buyback program. This transaction, executed through UBS AG London Branch, is part of the company’s strategy to manage its capital structure and enhance shareholder value, potentially impacting the company’s share price and investor relations.
British American Tobacco has disclosed transactions involving James Murphy, Director of Research and Science, who transferred shares between his own accounts and to Kirsti Nordgard Murphy, a person closely associated with him. These transactions, involving a total of 9,532 ordinary shares, were conducted outside a trading venue on April 11, 2025, and were executed for nil consideration, indicating internal adjustments rather than market-driven sales.
British American Tobacco has announced a transaction involving the repurchase of 130,021 of its ordinary shares as part of its ongoing buyback program. This move, authorized by shareholders, is intended to cancel the purchased shares, reducing the total number of shares in circulation and potentially enhancing shareholder value. Following this transaction, the company will have 2,201,202,720 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under regulatory guidelines.
British American Tobacco has announced a transaction involving Zafar Khan, Director of Operations, who transferred 15,617 ordinary shares between his own accounts for nil consideration. This transaction, conducted outside a trading venue, reflects internal financial adjustments and may have implications for the company’s internal share management but does not directly impact external stakeholders.
British American Tobacco has executed a buyback of 130,502 of its ordinary shares as part of its ongoing buyback program. The shares were purchased at prices ranging from 3,103 to 3,166 pence per share and will be canceled, reducing the total number of shares in circulation and potentially increasing the value for remaining shareholders. This move aligns with the company’s strategy to enhance shareholder value and optimize its capital structure.
British American Tobacco has announced a significant change in its voting rights structure due to an acquisition or disposal of shares by Spring Mountain Investments Ltd. The notification indicates a reduction in the voting rights percentage from 10.472723% to 9.996713%, which could impact the company’s governance and decision-making processes. This adjustment in holdings is part of the company’s ongoing strategic management of its shareholder structure.
British American Tobacco has executed a buyback of 132,945 of its ordinary shares, as part of a previously announced buyback program. The shares were purchased at prices ranging from 3,065 to 3,099 pence and will be canceled, reducing the total number of shares in issue. This move is likely to impact shareholder value and market perception, as it reflects the company’s strategy to manage its capital structure and return value to shareholders.
British American Tobacco has announced a transaction involving the transfer of 23,596 ordinary shares by Kingsley Wheaton, the Chief Corporate Officer, between his own accounts for nil consideration. This transaction, conducted outside a trading venue, signifies internal financial adjustments without immediate financial implications for the company or its stakeholders.
British American Tobacco has announced the repurchase of 133,375 of its ordinary shares as part of its ongoing buyback program. This move, authorized by shareholders, is intended to cancel the purchased shares, reducing the total number of shares in circulation and potentially increasing shareholder value. Following this transaction, the company will have 2,201,596,188 ordinary shares in issue, excluding treasury shares, which could influence shareholder notifications under regulatory guidelines.
British American Tobacco has announced the purchase of 131,300 of its ordinary shares as part of its ongoing buyback program. This transaction, authorized by shareholders, is part of the company’s strategy to enhance shareholder value by reducing the number of shares in circulation, potentially increasing the value of remaining shares and strengthening its market position.
British American Tobacco has executed a share buyback transaction, purchasing 136,481 of its ordinary shares at prices ranging from 2,932 to 3,076 pence per share. This move, part of a previously announced buyback program, aims to cancel the acquired shares, reducing the total number of shares in circulation and potentially enhancing shareholder value.
British American Tobacco announced a transaction involving the purchase of ordinary shares by Serpil Timuray, a Non-Executive Director, and Abdurrahman Murat Timuray. The transaction, conducted on the London Stock Exchange, involved the acquisition of 3,275 shares at a price of £32.00 each, totaling £104,800.00. This transaction reflects internal confidence in the company’s performance and may impact stakeholder perceptions positively.
British American Tobacco PLC announced the purchase of 128,977 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted with UBS AG, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder voting rights and interests.
British American Tobacco has announced that several of its executive directors and other key managerial personnel have purchased ordinary shares under the Partnership Share Scheme, a HMRC-approved Share Incentive Plan. This move, involving the acquisition of shares at a price of £31.83013 each, reflects the company’s commitment to aligning the interests of its leadership with those of its shareholders, potentially strengthening stakeholder confidence and reinforcing its market position.
British American Tobacco announced the repurchase of 130,448 of its ordinary shares as part of its ongoing buyback program. This transaction, authorized by shareholders, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder voting rights and interest notifications under regulatory guidelines.
British American Tobacco has announced the release and subsequent sale of shares under its 2022 International Share Reward Scheme. This notification involves several key managerial figures, including directors and regional directors, who have been allocated shares as part of their compensation package. The transactions, conducted outside a trading venue, reflect the company’s ongoing commitment to reward its management team, potentially impacting its financial reporting and stakeholder relations.
British American Tobacco has announced the award of ordinary shares to several executive directors and key managerial personnel under its 2025 Share Reward Scheme. This move, involving notable figures such as the Chief Executive and Chief Financial Officer, underscores the company’s commitment to incentivizing its leadership team, potentially impacting its operational focus and aligning management interests with those of shareholders.
British American Tobacco has repurchased 129,815 of its ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move reduces the number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests in line with regulatory requirements.
British American Tobacco announced the release of 67,109 ordinary shares to its Chief Executive, Tadeu Marroco, under the 2020 Long-Term Incentive Plan. Additionally, 31,544 shares were sold to cover tax liabilities associated with the vesting of this plan, generating approximately £1,003,730.08. This transaction highlights the company’s ongoing commitment to rewarding its executives while managing financial obligations effectively.
British American Tobacco p.l.c. announced the purchase of 128,601 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted through UBS AG, is part of a strategy to manage the company’s capital structure and enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in circulation and potentially impacting shareholder voting rights. This move reflects the company’s efforts to optimize its financial operations and maintain a strong market position.
British American Tobacco has announced its issued share capital as of March 31, 2025, which consists of over 2.2 billion ordinary shares with voting rights. The company also holds over 133 million shares in treasury. This information is crucial for shareholders to determine their voting rights interest or any changes to it, in compliance with the FCA’s Disclosure Guidance and Transparency Rules.
British American Tobacco has disclosed a transaction involving James Murphy, Director of Research and Science, who transferred 6,202 ordinary shares between his own accounts at nil consideration. This internal transaction, conducted outside a trading venue, reflects routine managerial adjustments and is unlikely to have significant implications for stakeholders or the company’s market positioning.
British American Tobacco has executed a share buyback program, purchasing 130,932 of its ordinary shares at an average price of 3,131.3859 pence per share. The company intends to cancel these shares, which will result in a total of 2,202,512,986 ordinary shares in issue, excluding treasury shares. This move is part of a strategy to optimize the capital structure and potentially enhance shareholder value.
British American Tobacco has announced the release of ordinary shares under its 2022 Restricted Share Plan to several key executives, including Jerome Abelman, James Barrett, Luciano Comin, and Michael Dijanosic. These transactions, which include sales to cover tax liabilities, reflect the company’s ongoing efforts to manage executive compensation and align management interests with shareholder value, potentially impacting the company’s financial strategies and stakeholder relations.
British American Tobacco announced the release and subsequent sale of shares under its 2022 Long-Term Incentive Plan for several key executives. This move involves the distribution of ordinary shares to directors and officers, such as Jerome Abelman, James Barrett, Luciano Comin, and Michael Dijanosic, with some shares sold to cover tax liabilities. The transactions, conducted outside a trading venue, reflect the company’s ongoing efforts to align executive compensation with long-term performance goals, potentially impacting shareholder value and executive engagement.
British American Tobacco announced the release of ordinary shares under the 2022 Deferred Share Bonus Scheme to several executives, including the Chief Executive and other directors. These transactions, which involved both the release and subsequent sale of shares to cover tax liabilities, highlight the company’s ongoing commitment to executive compensation and financial management strategies. The impact of these transactions on the company’s operations or market positioning is not explicitly detailed in the release, but such moves are typically part of broader efforts to align management incentives with shareholder interests.
British American Tobacco p.l.c. has executed a share buyback transaction, purchasing 132,272 of its ordinary shares from UBS AG as part of its ongoing buyback program. This move is intended to enhance shareholder value by reducing the number of shares in circulation, thereby potentially increasing the value of remaining shares. Following the cancellation of the purchased shares, the company will have 2,202,404,061 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under FCA regulations.
British American Tobacco has announced a change in major holdings, with Spring Mountain Investments Ltd acquiring a significant percentage of voting rights. This acquisition, which crosses a notable threshold, may impact the company’s governance and influence its strategic decisions, reflecting a shift in stakeholder dynamics.
British American Tobacco announced the repurchase of 112,000 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted through UBS AG, reflects the company’s strategy to manage its share capital and potentially enhance shareholder value. Following this purchase, the company will have over 2.2 billion ordinary shares in issue, excluding treasury shares, which may impact shareholder interests and regulatory disclosures.